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Abstract: Cytochrome P450 CYP3A4 is the main drug-metabolizing enzyme in 
the human liver, being responsible for oxidation of 50% of all pharmaceuticals 
metabolized by human P450 enzymes. Possessing a large substrate binding 
pocket, it can simultaneously bind several substrate molecules and often 
exhibits a complex pattern of drug–drug interactions. In order to better 
understand structural and functional aspects of binding of multiple substrate 
molecules to CYP3A4 we used resonance Raman and UV–VIS spectroscopy to 
document the effects of binding of synthetic testosterone dimers of different 
configurations, cis-TST2 and trans-TST2. We directly demonstrate that the 
binding of two steroid molecules, which can assume multiple possible 
configurations inside the substrate binding pocket of monomeric CYP3A4, can 
lead to active site structural changes that affect functional properties. Using 
resonance Raman spectroscopy, we have documented perturbations in the 
ferric and Fe-CO states by these substrates, and compared these results with 
effects caused by binding of monomeric TST. While the binding of trans-TST2 
yields results similar to those obtained with monomeric TST, the binding of 
cis-TST2 is much tighter and results in significantly more pronounced 
conformational changes of the porphyrin side chains and Fe-CO unit. In 
addition, binding of an additional monomeric TST molecule in the remote 
allosteric site significantly improves binding affinity and the overall spin shift 
for CYP3A4 with trans-TST2 dimer bound inside the substrate binding pocket. 
This result provides the first direct evidence for an allosteric effect of the 
peripheral binding site at the protein-membrane interface on the functional 
properties of CYP3A4. 
Graphical abstract: Synthetic dimers of the steroid testosterone are used to 
address directly the mechanisms of multiple substrate binding at the active 
site of cytochrome P450 3A4 and the role of substrate binding at a distal site 
in the control of allostery in this central enzyme of human drug metabolism. 
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1. Introduction 
CYP3A4 is the most abundant xenobiotic metabolizing 
cytochrome P450 in humans. It is responsible for the metabolism of 
approximately half of the drugs metabolized by P450 enzymes1 and as 
such affords unusually broad substrate specificity, with the substrate 
size spanning from ethanol (46 Da) to cyclosporine (1202 Da).2 Given 
its large and malleable substrate binding pocket, CYP3A4 can 
simultaneously bind several substrate molecules, often exhibiting 
substantial deviations from the simple Michaelis–Menten kinetics of 
enzymatic catalysis owing to homotropic or heterotropic cooperative 
interactions. Attaining a detailed mechanistic understanding of these 
interactions is important for the problem of drug–drug interactions 
mediated by cytochromes P450,3 a critical issue for development and 
clinical trials of new pharmaceutical compounds. Various approaches to 
this problem have been described previously,3,4,5,6,7,8,9 but no detailed 
molecular picture has yet emerged to help resolve the pressing need 
to better understand drug–drug interactions mediated by CYP3A4 or 
other important drug-metabolizing cytochromes P450, such as CYP2C9 
and CYP2D6. 
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Recently we developed a new method for deciphering the 
cooperative interactions of various substrates with CYP3A4, which is 
based on the global analysis of multiple experimental data sets 
obtained under identical conditions. This was accomplished using 
functionally competent reconstituted assemblies of CYP3A4 with P450 
reductase incorporated into Nanodiscs.10 Using testosterone (TST) as a 
model substrate, we were able to resolve the experimentally observed 
functional properties as a function of the substrate concentration and 
proved that at least three TST molecules can bind to each monomeric 
CYP3A4 Nanodisc assembly; i.e., ND:CYP3A4. The resolved stepwise 
stoichiometric dissociation constants (19, 37, and 56 μM) reveal that 
virtually no specific cooperative interactions between substrate binding 
sites is present (the cooperative free energy being estimated as less 
than 0.5 kcal/mol). Rather, the well-known non-Michaelis–Menten 
kinetics of TST hydroxylation by CYP3A4 is due to the different 
functional properties of the enzyme carrying one, two, or three 
substrates. While binding of the first TST molecule does not result in 
any product formation, the second binding event turns on the full 
catalytic activity of the enzyme and the third binding step significantly 
improves the efficiency of CYP3A4 catalysis, with fewer redox 
equivalents being consumed per one productive turnover.10 
However, although the above referenced efforts have provided 
thorough documentation of functional properties, the structural basis 
for such complex effects caused by interactions of multiple steroid 
molecules with CYP3A4 remains obscure. Currently there are two X-ray 
structures of CYP3A4 with two organic molecules inside the substrate 
binding pocket, but both represent Type II inhibitors with one molecule 
coordinating to the heme iron as the sixth axial ligand, while another 
packs on the side11 or on top12 of the first. The only structure of 
CYP3A4 with steroid progesterone bound as a substrate reveals a 
peripheral binding site on the outside of the F-F′ and G-G′ loops.13 
Recent efforts to crystallize CYP3A4 occupied with a specified number 
of progesterone molecules also ended with the structures with only 
one steroid molecules at the peripheral site,14 very similar to the one 
reported earlier. This result confirms that obtaining crystals of CYP3A4 
with a given number of substrate molecules presents difficult 
challenges. In addition, crystallization of cytochromes P450 is currently 
accomplished only using soluble forms of these monotopic membrane 
proteins, with no lipid bilayer present. Thus, more information about 
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the positioning of two steroid molecules inside the substrate binding 
pocket of CYP3A4 and their mutual interactions resulting in the 
functionally active enzyme-substrate complex, can most conveniently 
be obtained using spectroscopic methods using CYP3A4 incorporated 
into the Nanodisc lipid bilayer while the high affinity binding site for 
steroids in CYP3A4 is most likely located at the protein-membrane 
interface.15 
Recently we have published a thorough comparison of CYP3A4 
interacting with several substrates, including erythromycin, 
bromocryptine and TST, using resonance Raman (rR) spectroscopy16 to 
acquire high quality spectra for the ferric form and the ferrous CO 
adducts. Various perturbations of the vibrational modes of the heme 
and the internal modes of the Fe-CO fragment provided useful insight 
into the active site structural changes imposed by binding 
erythromycin, bromocryptine or saturating amounts of TST. Indeed, 
these studies suggested, among other useful facts, that binding of 
bromocryptine within the CYP3A4 substrate pocket induced 
functionally significant out-of-plane distortion of the heme plane and 
vinyl group disposition that was only later confirmed by 
crystallographic studies.17 However, because of the essentially non-
cooperative binding of TST to CYP3A4 and strong overlap of population 
distributions of CYP3A4 binding intermediates with one, two or three 
bound TST molecules, it was impossible to confidently assign the 
observed rR spectral changes to a particular binding event so as to 
allow for definitive structural interpretation. Fortunately, the nearly 
coincident report of the synthesis of TST dimers of different 
configurations18 opened a new opportunity for the spectroscopic study 
of possible binding modes of steroids by CYP3A4, the results of which 
are reported herein. 
The essential advantage of these TST dimers is that comparison 
of the rR spectra of CYP3A4 in the presence of dimers with known 
spatial structures can remove the ambiguity of the earlier work, 
helping to remove the heterogeneity of the system and overlap of 
signals from multiple binding intermediates. Owing to the large size of 
TST dimers we expect their binding to CYP3A4 to follow a simple 1:1 
stoichiometry, resulting in much better characterized CYP3A4 
complexes with two TST molecules packed inside the substrate binding 
pocket with different configurations. Specifically, in cis-TST the two 
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steroid moieties are positioned one on top of the other in almost 
parallel orientation, while in trans-TST they are separated in space 
( Fig. 1), so that the binding in CYP3A4 is expected to position one 
steroid near the heme iron with the second one extended towards the 
entrance to the binding pocket. Comparison of the spectral 
characteristics of these two CYP3A4–TST dimer complexes with those 
of the previously measured CYP3A4 complexes with monomeric TST 
provides information regarding steroid binding modes to CYP3A4. In 
addition, titration experiments with mixtures of trans-TST2 dimer with 
TST monomer help reveal the role of the allosteric remote binding 
site7,14,15,19,20,21 in steroid binding to CYP3A4 monomer incorporated in 
the 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipid 
bilayer of Nanodiscs. 
 
Fig. 1. The structures of TST dimers, cis-TST2 (A, B) and trans-TST2 (C, D) are shown: 
top view with steroid moiety in the plane of the figure (A, C) and side view (B, D). For 
cis-TST2 the X-ray structure of diacetate dimer is shown as reported in,18 while 
structure of trans-TST2 is obtained from that of cis isomer by rotation around double 
bond connecting two TST monomers. 
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2.1. Sample preparation 
2.1.1. Materials 
Testosterone dimers were synthesized as described earlier18 
from 7α-allyltestosterone acetate as a precursor. The latter was made 
using a three-step reaction sequence from testosterone. The 
dimerization step performed using Hoveyda–Grubbs' metathesis 
catalyst22,23 yielded a mixture of cis and trans dimers diacetate (1:2 
ratio). The cis and trans dimers diacetate were separated by flash 
column chromatography using distilled solvents (hexane/acetone, 
4:1).18 Once separated, thin layer chromatography showed a single 
homogeneous spot. Hydrolysis of the pure diacetate dimers were 
performed separately to yield the final cis-TST2 and trans-TST2 dimers. 
The final dimers remained homogeneous by thin layer 
chromatography. They were characterized by 1H and 13C NMR spectra 
and were exempt of any impurities. X-ray structure of the diacetate 
cis-TST2 dimer confirmed the results of synthesis and separation, 
together with IR and NMR spectroscopy and mass-spectrometry.18 All 
other chemicals of highest purity were from Sigma-Aldrich and used 
without further purification. 
2.1.2. Protein expression and purification 
Expression and purification of CYP3A4 and membrane scaffold 
protein (MSP1D1) and incorporation of CYP3A4 in POPC Nanodiscs was 
performed as described.21,24 CYP3A4 with a C-terminal pentahistidine 
tag was expressed from the NF-14 construct in the PCWori + vector 
generously provided by Dr. F. P. Guengerich (Vanderbilt University, 
Nashville, TN). Assembly of CYP3A4 in Nanodiscs was done by gradual 
removal of detergent from the mixture of solubilized POPC lipids, 
CYP3A4 and MSP1D1 scaffold protein using Biobeads.24  
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2.2. Resonance Raman measurements 
2.2.1. Preparation of samples for rR measurements 
The samples of ~ 50 μM CYP3A4 in Nanodiscs were in 100 mM 
potasium phosphate buffer, pH 7.4. The TST, cis-TST2 and trans-TST2 
bound samples contained 450 μM concentrations of TST, 63 μM of the 
cis-TST2 and 75 μM of trans-TST2, and the spin state conversion, 
estimated by electronic absorption spectrophotometry was 84%, 100% 
and 75% high spin, respectively. The carbonmonoxy ferrous 
ND:CYP3A4 samples were prepared as follows. The 100 μL of ~ 50 μM 
ferric ND:CYP3A4 sample was placed in a 5 mm NMR tube (WG-5 
Economy, Wilmad), closed with a rubber septum and saturated with 
CO gas for ~ 30 min, while gently shaking in an ice bath. The sample 
was reduced by addition of ~ 2–4 M equivalents (~ 2–3 μL) of sodium 
dithionite dissolved in freshly degassed 100 mM potassium phosphate 
buffer, pH 7.4. The full conversion of ferric sample to ferrous CO 
adducts was monitored by UV–Vis, with no evidence being found for 
the presence of P420 before and after rR measurements, e.g., the 
ferrous CO P450 has a Soret at 448 nm and a Q-band at 552 nm, 
while Soret band of ferrous CO P420 is at 420 nm and Q-bands at 
around 540 nm and 570 nm.25  
2.2.2. Acquisition of rR spectra 
The resonance Raman spectra of ND:CYP3A4 samples were 
acquired using a Spex 1269 spectrometer equipped with a Spec-10 
LN-cooled detector (Princeton Instruments, NJ). The ferric CYP3A4 
samples were measured with the 406.7 nm excitation line from a Kr+ 
laser (Coherent Innova Sabre Ion Laser) while the Fe(II)–CO adducts 
were excited using the 441.6 nm line provided by a He–Cd laser (IK 
Series He–Cd laser, Kimmon Koha CO., LTD.). The rR spectra were 
collected using back scattering (180°) geometry with the laser beam 
being focused by a cylindrical lens to form a line image on the 
sample.26 The laser power was adjusted to ~ 10 mW, while for ferrous 
CO adducts it was kept at ~ 1 mW to minimize photodissociation. The 
slit width was set at 150 μm and the 1200 g/mm grating was used. 
Spectra were calibrated with fenchone (Sigma-Aldrich, WI), toluene-
2H6 and acetone-2H6 (Cambridge Isotope Laboratories, Inc., MA) and 
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processed with Grams/32 AI software (Galactic Industries, Salem, 
NH). The peak fitting procedure was performed as previously 
published.16  
2.3. Spectral titration studies 
For the spectral titration studies the DMSO stock solutions of 
TST dimers have been used so that the final concentration of DMSO 
would not exceed 2%. UV–VIS spectral titrations have been done 
using Cary 3 spectrophotometer in the 10 mm quartz cells at the 
constant temperature 25 °C and ND:CYP3A4 concentration ~ 1 μM. 
Spectra were collected in the range 350–750 nm and analyzed using 
Singular Value Decomposition algorithm implemented in MATLAB as 
described earlier.10 The second singular value corresponding to the 
difference spectrum was used for the fitting as a function of the 
substrate concentration with non-cooperative Langmuir equation or 
with Hill equation. Mixed titration experiments were done using the 
mixture of monomeric TST and trans-TST2 at the constant 4:1 M ratio 
in order to probe the possible effect of monomeric TST binding to the 
CYP3A4 at the peripheral binding site as explained in Results and 
Discussion section. 
3. Results and discussion 
3.1. Resonance Raman studies 
3.1.1. Ferric ND:CYP3A4 
The high frequency rR spectrum of substrate-free ND:CYP3A4 is 
shown in Fig. 2 trace A. The dominant oxidation state marker band, ν4 
at 1372 cm− 1, indicates that the sample is in the ferric state and the 
spin state markers at 1502 cm− 1 (ν3), 1568 cm− 1 (ν2) and 1643 cm− 1 
(ν10) are characteristic for low-spin (S = 1/2) state; it is noted, 
however, that the presence of a low intensity ν3 mode at around 
1488 cm− 1 signals the presence of a small population of a high spin 
component. The percentage of high spin component in this sample was 
calculated according to previously reported procedure27 and was 
estimated to be 15%, in good agreement with the value obtained from 
UV–Vis spectrophotometry and previously published results.16  
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The spectral peaks associated with vinyl stretching modes are 
seen at 1625 cm− 1 and 1636 cm− 1. Addition of a saturating amount of 
monomeric TST substrate (trace B) resulted in substantial spin state 
conversion to high spin (calculated 74% HS from rR data and 84% 
from electronic absorption spectrophotometric data) as is manifested 
the clear appearance of the high spin state marker modes; namely, 
the ν3 mode at 1488 cm− 1 and the ν2 at 1570 cm− 1. The ν10 high spin 
mode expected near 1625 cm− 1 is buried in envelope containing the 
ν(C C) stretching modes. These results are consistent with previously 
published data.16  
 
Fig. 2. The high frequency rR spectra of ferric ND-CYP3A4 samples in their substrate-
free form (A), bound with excess of monomeric TST (B), trans-TST2-bound (C), cis-
TST2-bound (D), trans-TST2-bound minus DMF (E), cis-TST2-bound minus DMF (F) and 
DMF in phosphate buffer (G). Excitation line 406.7 nm, spectra normalized to the ν3 
modes. 
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The spectra of trans-TST2 (trace C) and cis-TST2 (trace D) 
bound samples contain modes associated with DMF that was used as a 
solvent for the stock solutions of these substrates (trace G). The most 
intense modes associated with the DMF solvent are observed at 
1420 cm− 1 and 1441 cm− 1. In order to avoid complication that might 
arise from overlap of CYP3A4 modes with these solvent bands, the 
spectrum of DMF was subtracted from the spectra of TST-dimer bound 
samples, with the resultant spectra being presented in trace E for 
trans-TST2 and trace F for cis-TST2 samples, respectively. As can be 
clearly seen, trans-TST2 causes only partial spin state conversion upon 
binding (calculated 49% HS), cis-TST2 forces almost complete spin 
state conversion (calculated 92% HS). 
The corresponding spectra in the low frequency region are 
presented in Fig. 3, the left panel presenting CYP3A4 spectra was 
normalized to the ν8 mode for a better view of small intensity modes, 
while the right panel was normalized to the intense ν7 mode at 
674 cm− 1. As was the case in the high frequency region, the samples 
containing cis-TST and trans-TST contain dimethylformamide (DMF) 
(traces C and D), with the DMF bands being subtracted to yield traces 
E and F. The relative intensity ratios of Raman modes of DMF solvent 
shown at the bottom of left and right panels have not been altered 
when splitting the full spectrum. The ferric substrate-free (SF) (trace 
A) and TST (trace B) samples exhibit similar spectral pattern to that 
observed previously;13 e.g., the spectrum of TST-bound sample 
exhibits significantly enhanced out-of-plane (OOP) modes at 317 cm− 1 
and 499 cm− 1 as compared to the spectrum of substrate-free form. 
The spectrum of the TST-bound sample (trace B) contains slightly 
enhanced OOP modes as compared to the spectrum of the trans-TST2-
bound sample (trace E). This slight alteration reflects smaller 
percentage of high spin population in the trans-TST2-bound and is 
consistent with observations in the high frequency region. On the 
other hand, the low frequency rR spectrum of the ferric cis-TST2-bound 
sample exhibits relatively strong enhancement of OOP modes, stronger 
enhancement of in-plane vinyl mode at 411 cm− 1 that is accompanied 
by the upshift of the propionate bending mode by 2 cm− 1 and the 
activation of a δ(Cβ-C) bending mode, ν51, appearing at 327 cm− 1, 
which might be associated with another propionate bending motion. 
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Fig. 3. The low frequency rR spectra of ferric ND:CYP3A4 samples in their substrate-
free form (A), bound with excess of monomeric TST (B), trans-TST2-bound (C), cis-
TST2-bound (D), trans-TST2-bound minus DMF (E), cis-TST2-bound minus DMF (F) and 
DMF in phosphate buffer (G), excitation line 406.7 nm. The left panel of CYP3A4 
spectra is normalized to the ν8 modes for a better view of small modes, while the right 
panel is normalized to the ν7 mode. The relative intensities of the Raman bands in the 
spectrum of DMF in buffer are unchanged. 
Collectively, the binding of trans-TST2 substrate to the ferric 
protein causes similar spectral changes to those seen when binding of 
monomeric TST molecules, with slightly smaller spin state conversion. 
Conversely, binding of cis-TST2 substrate causes large spin state 
conversion (92% HS by rR measurement), significant changes in heme 
planarity and changes in the disposition of heme peripheral groups. 
These observations imply that the trans-TST2 substrate binds in a 
similar manner as a pair of the monomeric TSTs, while the cis-TST2 
dimer occupies significantly different position than do two TST 
monomers. 
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3.1.2. Ferrous CO adducts of ND:CYP3A4 
The ν(Fe–C) stretching modes of SF and TST-bound ND:CYP3A4 
are observed as wide, asymmetrical envelopes, with components at 
476 cm− 1 and 491 cm− 1, respectively (Fig. 4). Generally, these 
spectra can be deconvoluted into two Fe–C modes, centered at 
476 cm− 1 and 491 cm− 1, with the lower frequency one being dominant 
in the spectrum of SF sample and the higher frequency one being 
dominant for TST-bound sample, in agreement with previously 
published data.16 The corresponding two CO stretching modes are seen 
at 1953 cm− 1 and 1929 cm− 1, respectively, and are observed in 
spectra of both SF and TST-bound samples, but with reversed 
intensities (Fig. 5). There are no significant changes in heme mode 
disposition upon binding of the TST molecules (Fig. 4 and Fig. 5). The 
ferrous ion of CO adduct is in a six coordinate, low-spin state, as seen 
by the positions of the oxidation state marker (ν4), at 1370 cm− 1, and 
the spin state marker band (ν3), at 1496 cm− 1, data consistent with 
those previously published (Fig. 5).16  
 
Fig. 4. The low frequency rR spectra of ferrous CO adducts of ND:CYP3A4 samples in 
theirsubstrate-free form (A), bound with excess of monomeric TST (B), trans-TST2-
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bound (C) and cis-TST2-bound (D). Excitation line 441.6 nm, the spectra were 
normalized to the ν7 mode. The Fe–C bands in the 450–700 cm−1 region were 
deconvoluted using 50% Gaussian and 50% Lorentzian functions as described 
before.16 Black solid line — experimental data, blue solid line — fitted spectra, red 
dotted line — modes associated with ν(Fe–C) modes, black dotted line — other modes 
in this region. The horizontal numbers indicate the bandwidths of the ν(Fe–C) modes 
reflecting the effects of the substrate binding on the Fe–C–O fragment. 
 
 
Fig. 5. The high frequency rR spectra of ferrous CO adducts of ND:CYP3A4 samples in 
their substrate-free form (A), bound with excess of monomeric TST (B), trans-TST2-
bound (C) and cis-TST2-bound (D). Excitation line 441.6 nm, the spectra were 
normalized to the ν4 mode. 
The spectrum of CO bound ferrous trans-TST2 sample exhibits a 
wide ν(Fe–CO) envelope cantered at around 483 cm− 1, which can be 
reasonably deconvoluted in the same way as the previously discussed 
spectra of SF and TST-bound samples. However, the lower frequency 
Fe–C stretching mode is upshifted to 479 cm− 1 (with it corresponding 
ν(C–O) mode accordingly shifting down by 2 cm− 1); the higher 
frequency one is observed at 491 cm− 1, with its ν(C–O) at 1929 cm− 1 
also unshifting. The δ(Fe–C–O) bending modes for all three samples, 
SF, TST-bound and trans-TST2-bound are observed at around 
558 cm− 1. 
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The unique spectrum of the cis-TST2-bound sample exhibits only 
one, very intense and sharp, ν(Fe–C) stretching mode at 495 cm− 1; 
this mode is accompanied by strong δ(Fe–C–O) bending mode seen at 
560 cm− 1 and a ν(CO) stretching mode at 1926 cm− 1 (Fig. 5). More 
careful analysis of the 450–700 cm− 1 regions reveals that the peak 
area ratios of δ(Fe–C–O) bending mode to the ν7 mode is 1:28 for SF 
sample, 1:31 for TST-bound sample, 1:32 for trans-TST2 and 1:11 for 
cis-TST2. The approximately three times larger intensity of δ(Fe–C–O) 
bending mode in cis-TST2 sample implies unusually large bending of 
the Fe–C–O conformer.28 The additional strong intensity of the ν(Fe–C) 
and its narrow bandwidth indicate also very rigid conformational 
restriction of the Fe–C–O fragment imposed by the presence of cis-
TST2 substrate. It is noted that the only significant changes in heme 
modes upon binding all three substrates to the ferrous CO adducts is 
the slight decrease in intensity of the higher frequency bending mode 
(at 421 cm− 1) of the cis-TST2 dimer. Thus, the rR data of ferric and 
ferrous CO adducts of the trans-TST2- and cis-TST2-bound samples, 
although reflecting isolated states with only two TST molecules, are 
very different from each other. The trans-TST2 substrate causes 
changes in the spectra of ferric and ferrous CO states similar to those 
observed using excess of monomeric TST, therefore representing the 
state more similar to the natural situation with two monomeric TST 
bound. On the other hand, binding of the cis-TST2 substrate in the 
ferric state causes unusually strong spin shift. It also causes relatively 
strong heme deformation as seen by increase in intensity of the OOP 
modes as well as changes in the heme peripheral groups (Fig. 3, trace 
F). Moreover, the rR spectra of ferrous CO adduct show that the cis-
TST2 substrate, although generally not affecting the heme modes in 
this ligated state, does cause strong deformation of the Fe–C–O 
fragment, indication of different occupation of heme pocket as 
compared to the monomeric TST and the trans-TST2 dimer. 
3.2. Spectral binding studies 
Titration of CYP3A4 with trans-TST2 and cis-TST2 were studied 
using absorption spectroscopy. As shown in Fig. 6, binding of cis-TST2 
is very tight, with Kd = 0.3 μM and almost complete conversion from 
predominantly low-spin to the high spin state (Fig. 6, A and B). For the 
trans-TST2 dimer binding is 25-fold weaker, with Kd = 8 μM and spin 
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shift at maximum ~ 75% (Fig. 6, C and D). Therefore, interactions of 
ND:CYP3A4 with cis-TST2 and trans-TST2 show significant variations in 
both affinity and the amplitude of the spin shift, indicating 
substantially different binding modes. Both dimers have identical 
chemical structure, but significant difference in their shapes results in 
the large difference in their affinities. Very tight binding of cis-TST2 
and ~ 100% high spin conversion suggest close packing of this TST 
dimer in the immediate vicinity of the heme with complete 
displacement of water as the sixth ligand to the iron. Binding of the 
trans-TST2 dimer results in a looser fit in the active site, as judged by 
incomplete spin shift reached at saturation. The inability of trans-TST2 
to completely displace the water molecule ligating to the heme iron 
suggests more dynamic positioning of this TST dimer inside the 
substrate binding pocket and possible existence of multiple conformers 
with different distances of steroid moiety from the heme. This 
suggestion is strongly supported by the rR data observed for these two 
cases, where the trans-TST2 dimer exhibits two ν(Fe–C) and two ν(C–
O) modes as opposed to the single (sharp) modes observed for the 
cis-TST2 dimer. This loose binding and easier access of water to the 
substrate binding pocket may explain, at least in part, the ~ 25-fold 
lower affinity of CYP3A4 for the trans-TST2 than that observed for cis-
TST2. Although for trans-TST2 dimer binding is substantially weaker 
than for cis-TST2, it is still more tight than with monomeric TST 
(Kd = 19 μM and 37 μM for the first and second binding event with TST 
monomer, (10)). The higher affinity of both TST dimers to CYP3A4 
underlines important contribution of hydrophobic interactions of 
lipophilic substrates with xenobiotic metabolizing cytochromes P450.29  
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Fig. 6. Titration of ND:CYP3A4 with cis-TST2 (top) and trans-TST2 (bottom). 
Experimental results (filled circles) shown as fractions of total spin shift as a function 
of substrate concentration have been fitted with the regular Langmuir binding 
isotherm calculated using exact solution for the tight binding case (top), or Hill 
equation for the cooperative binding (bottom). 
Because of the large size of both TST dimers, simultaneous 
incorporation of two such molecules into the active site of CYP3A4 is 
highly disfavored. As expected, no apparent cooperativity is seen in 
the spectral titration curves shown in Figs. 6B and D. The fit of the 
data shown in Fig. 6D is slightly better when Hill equation is used 
(nH = 1.2), although low value of the Hill coefficient also confirms non-
cooperative binding in CYP3A4.6 Minor deviations from the Langmuir 
isotherm may be attributed to partitioning of the trans-TST2 into the 
lipid bilayer of POPC Nanodiscs, although the effect of such partitioning 
is small at low concentration of Nanodiscs (1 μM ND:CYP3A4 
concentration used in titration experiments corresponds to ~ 10− 4 
volume fraction of lipid phase in solution). While the possibility of 
interaction of the trans-TST2 with peripheral site of CYP3A4 cannot be 
ruled out, results of titration experiments with both TST dimers 
suggest the simple single-site binding and do not indicate any multisite 
cooperative interactions. 
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In order to explore the possible effect of binding at the 
peripheral allosteric site we performed titration of CYP3A4 with the 
mixture of monomeric TST with trans-TST2, assuming that monomeric 
TST will be able to bind to the peripheral site with no competition from 
TST dimer. Such combination of two substrates, of which one can bind 
to the allosteric site with relatively high affinity10 while the other one 
does not, provides an excellent opportunity for evaluating the 
allosteric effect of TST monomer at the peripheral site on the binding 
of TST dimer inside the substrate binding pocket. 
Titration with the mixture of monomeric TST with trans-TST2 
(4:1 ratio) results in ~ 2-fold higher apparent affinity with the Kd 
decreasing from 8 μM to 3.4 μM. In addition, a significant shift of the 
spin equilibrium towards high spin configuration is observed at 
saturation, changing the remaining LS fraction from 25% to ~ 4%. 
This effect of TST monomer can be attributed to binding at the remote 
allosteric site15 rather than to insertion into the active site in addition 
to the bound trans-TST2, which is unlikely for steric reasons. 
Competitive replacement of the trans-TST2 by two monomeric TST 
molecules can also be ruled out because of low TST concentration in 
the mixed titration experiment. From earlier studies performed under 
similar conditions10,30 it is known that high spin conversion in CYP3A4 
in Nanodiscs can be reached only at TST concentrations ~ 200 μM, i.e. 
much higher than the maximum 75 μM concentrations reached in this 
study (Fig. 7, mixed titration). Thus, binding of monomeric TST in the 
active site would require significant increase of CYP3A4 affinity to this 
substrate in the presence of trans-TST2, for which we have no 
experimental evidence. Therefore, our observations provide a direct 
evidence of the functionally important allosteric effect caused by TST 
monomer binding at the remote site when another substrate is present 
in the substrate binding pocket. Similar effects have been observed in 
the mixed titration of CYP3A4 with carbamazepine and various 
steroids,15 in which apparent positive cooperativity was detected by 
the shift of the midpoint of the spin shift transition towards the lower 
concentrations of substrates. Taken together, these experimental 
results suggest the presence of the general regulatory role of steroids 
upon CYP3A4 catalysis (at least with some substrates) via binding at 
the remote allosteric site formed at the interface between F-F′ and G-
G′ loops of the protein and lipid head groups. 
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Fig. 7. Titration of ND:CYP3A4 with the mixture of trans-TST2 and monomeric TST at 
1:4 ratio. 
4. Discussion 
Currently, there is no X-ray structure of CYP3A4 with steroid 
substrates bound in the substrate binding pocket, the only ones, 
having a progesterone bound,13,14 have it located at the peripheral 
non-productive site. Several structures of other cytochromes P450, 
which have one steroid substrate molecule in a productive position, 
including CYP154C5,31 CYP7A1,32 CYP11A1,33,34 CYP11B2,35 CYP19A1,36 
human CYP17A1,37 fish CYP17A1 and CYP17A2,38 CYP46A1,39 CYP5140 
and CYP125,41 demonstrate various orientations of the steroid moiety 
with respect to the heme iron and I-helix, the main structural elements 
shaping the P450 active site. However, the presence of the second 
steroid in the active site is expected to impose significant restrictions 
on the stereochemistry of packing of two substrate molecules within 
the substrate binding cavity. This can be seen in the only two X-ray 
structures of cytochromes P450 with two steroid molecules bound 
inside the active site, P450eryF with two androstenedione molecules,42 
and CYP21A2 with two 17OH-progesterone molecules.43 In the former 
case two steroids are packed one over another, almost parallel to the 
I-helix, while in the latter the second steroid is significantly shifted 
with respect to the first one. In the present work, the synthetic TST 
dimers with cis- and trans-configurations allowed us to compare these 
two binding modes for two TST monomers to CYP3A4 in a 
straightforward manner. 
Our results show that both cis-TST2 and trans-TST2 can bind to 
the CYP3A4, which possesses highly flexible active site capable to 
accommodate such different substrates. However, cis-TST2 binds much 
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more tightly and induces ~ 100% spin shift, presumably due to more 
compact shape and better fit to the substrate binding pocket as 
compared to trans-TST2. One the other hand, it is important to 
emphasize that the trans-TST2 dimer exhibits spectral (rR) properties 
and binding affinity more closely matching those extracted for the case 
with two monomeric TST substrates. This is in agreement with its 
more flexible and somewhat larger shape in comparison to the cis-
TST2 dimer (see Fig. 1) that allows comparable binding interactions to 
the CYP3A4 as do two TSTs. 
Comparison with rR studies of other cytochromes P450 reveals a 
variety of observed spectral changes and corresponding structural 
perturbations caused by substrate binding. No distinct changes in the 
heme modes were observed in the human CYP17A1 upon binding of 
the natural substrates progesterone and others, despite almost 100% 
spin shift caused by progesterone binding.44 Similarly, no perturbation 
of the heme modes were detected upon substrate binding to CYP2B4.45 
However, in CYP101 significant perturbation of the low frequency 
heme modes caused by substrate binding were observed46,47 and 
attributed to substantial out-of-plane movements of the vinyl side 
chains and perturbations of the propionate side chains. Similar 
perturbations were observed also in CYP51 from Mycobacterium 
Tuberculosis upon binding of azole inhibitors48 and substrate 
dihydrolanosterol;49 such changes were also seen in human 
prostacycline synthase in the presence of some substrate analogs, but 
not inhibitors.50  
Interestingly, there are other examples of stronger binding of 
dimers of substrates to CYP3A4. Synthetic dimers of furanocoumarins 
proved to be very strong inhibitors of TST hydroxylation by 
CYP3A4.51,52 Several natural polyphenols, such as ε-viniferin, the dimer 
of resveratrol,53 and rivulobirin-A, a natural furanocoumarin dimer,54 
also appear to be potent inhibitors of CYP3A4. These results are 
consistent with the general approach for using synthetic dimers of 
CYP3A4 substrates or inhibitors to improve binding. 
In conclusion, our results directly demonstrate the ability of 
CYP3A4 to accommodate two TST molecules inside the substrate 
binding pocket in various configurations. The degree of spin shift and 
binding affinity strongly depend on the geometry and overall size of 
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TST dimers. In addition, interaction of TST monomer with CYP3A4 at 
the remote site of the enzyme significantly increases spin shift and 
binding affinity for the trans-TST2. This observation confirms earlier 
suggestions on the possible allosteric effect caused by binding of 
steroids at the allosteric site,7,10,19,20,21 tentatively the one identified as 
the progesterone binding site by X-ray crystallography13  
Table of Abbreviations 
DMF dimethylformamide 
HS high-spin fraction 
LS low-spin fraction 
ND:CYP3A4 Nanodiscs with CYP3A4 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
rR resonance Raman 
SF substrate free 
TST testosterone 
cis-TST2 cis-testosterone dimer 
trans-TST2 trans-testosterone dimer 
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